SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.

Advertisement


Inside Views

Submit ideas to info [at] ip-watch [dot] ch!

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

WHO Should Have The Evidence? Ben Goldacre Refutes WHO Director’s Claim

“Bad Science” adversary and journalist, Dr Ben Goldacre, this week challenged WHO Director of Ethics and Social Determinants of Health, Dr Rüdiger Krech, on his understanding of published evidence.





Latest Comments
  • As it happens, I own and create "intellectual prop... »
  • So long term planning of the UN Development Decade... »

  • For IPW Subscribers
    A directory of IP delegates in Geneva. Read more>

    A guide to Geneva-based public health and intellectual property organisations. Read More >

    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >


    Public Health

    24/05/2013: World Health Assembly: Members Debate US Proposed Advisory Meeting On Health R&D
    24/05/2013: WHO Should Have The Evidence? Ben Goldacre Refutes WHO Director’s Claim
    24/05/2013: World Health Assembly: Groups Seek To Return Focus To ‘Broken’ Medical R&D System
    23/05/2013: World Health Assembly: Draft Of NCD Action Plan Shows Compromises On IPRs
    22/05/2013: World Health Assembly: Drafting Group Progressing On NCDs
    20/05/2013: Infojustice: Trans-Pacific Partnership IP Chapter Stalled
    20/05/2013: WHO Director Highlights Noncommunicable Diseases, Pandemics; Blasts Industry Counter-Efforts
    20/05/2013: Conference On Journalism And Health Looks At WHA Issues
    17/05/2013: WIPO Programmes Seek To Bridge IP And Climate Change, Global Health
    17/05/2013: World Health Assembly: R&D, NCDs, Pandemics Top Agenda
    15/05/2013: WHO Stats Show Medicines Remain Out Of Reach Of Poorest Patients
    13/05/2013: WIPO Committee On Development This Week: North-South Differences
    06/05/2013: Cuba Files WTO Dispute Against Australia Over Tobacco Plain-Packaging
    01/05/2013: Experts Offer Perspectives On R&D Policies In The Public Health Domain
    30/04/2013: UNCTAD Handbook: IP And The CBD Protocol On Genetic Resources
    29/04/2013: UNCTAD: IPRs In Health, Research, Cosmetics, Meet Access & Benefit Sharing
    24/04/2013: Inside Views: Global Public-Private Partnerships Against IP Crimes: How Interpol Avoided The Failures Of WCO And WHO
    23/04/2013: US Supreme Court May Invalidate Gene Patents, But Create Little Change
    22/04/2013: Curbing Vaccine Costs Key To Extending Global Immunisation Reach
    15/04/2013: Inside Views: The Novartis Decision: A Tale Of Developing Countries, IP, And The Role Of The Judiciary
    11/04/2013: Reports: Obama’s Proposed 2014 Budget Favours Patent Office, R&D, Generic Drugs
    10/04/2013: Study: Misuse Of Patent System Affecting Health System In Australia
    09/04/2013: Health Research Colloquium Calls On Countries To Invest More In R&D
    09/04/2013: WIPO Hails India’s Accession To Trademark System; India Advocates Balance
    05/04/2013: North American Universities Seen Failing To Promote Socially Responsible Licensing
    04/04/2013: Inside Views: The Judgment In Novartis v. India: What The Supreme Court Of India Said
    03/04/2013: Australian Pharmaceutical Patents Review Draft Report Critical Of Patent Extensions, R&D Funding
    01/04/2013: Novartis Loses Patent Bid: Lessons From India’s 3(d) Experience
    01/04/2013: India Dismisses Antitrust Complaint Against Gilead Sciences
    28/03/2013: East African Community Doubles Efforts To Boost Local Drug Production
    27/03/2013: Biovision: Personalised Medicine, Climate Change, Sustainability Need Innovation
    26/03/2013: Rules Changing For Life Sciences Tech Transfer, IP, Speakers Say
    25/03/2013: Global Fund Receives USD 1.65B From US Congress; Names New Board Leadership
    23/03/2013: US Supreme Court To Hear Arguments On Pay-For-Delay Drug Deals
    21/03/2013: Global Pharma Companies See Battle For Survival In Pakistan
    19/03/2013: Pharma, International Red Cross Combine To Fight NCDs
    18/03/2013: Tuberculosis: WHO, Global Fund Call For Mobilisation Of Funds As Resistance Rises
    18/03/2013: Nearly 50 Groups Demand IPRs Out Of EU-US FTA
    18/03/2013: UN Agencies To Examine International Standards, Potential Value For Developing Countries
    18/03/2013: African Ministers Focus On IP Role In Innovation For Development; Less On Flexibilities
    13/03/2013: On Plant Patents, EPO President Backs Industry, Disregards EU Parliament, Group Says
    12/03/2013: Leaked IP Chapter Of India-EU FTA Shows TRIPS-Plus Pitfalls For India, Expert Says
    11/03/2013: Digital Rights, Health Concerns As TPP Talks Continue
    11/03/2013: Swiss Perspectives On The Success Of Its National Innovation Model
    07/03/2013: WTO Hears Health, Economic Considerations Of Plain Packaging For Tobacco
    05/03/2013: Bayer Will Appeal India Compulsory Licence On Its Cancer Drug
    04/03/2013: India’s First Compulsory Licence Upheld, But Legal Fights Likely To Continue
    04/03/2013: Patent Pool-ViiV Collaboration On Paediatric HIV Sparks Reactions, Hope
    01/03/2013: Global Fund Launches New Funding Model
    01/03/2013: WIPO Patent Law Committee Cinches Agreement On Future Work
    Your IP address is 79.171.81.124